Abstract: The invention concerns a device for the fixation and manipulation of those tissues which are at least temporarily suitable for being fixed by suction. Hereby, tissues are understood to be, in addition to organic tissues, such as e.g. tissues of animals and humans, also inorganic tissues, such as films or textiles. In particular, the invention concerns a device for the fixation and manipulation of tissues which surround sensitive organs, such as e.g. the pericardium in humans. Furthermore, the invention concerns a method for the fixation and manipulation and, in particular, for puncturing of such tissues or the underlying areas.

Abstract: The invention relates to an arrangement which can be fixed to the inside of a cavity by means of fixing means which are associated with said arrangement. Said fixing means fix the arrangement in relation to at least one part of the wall of the cavity which is to be examined, wherein the arrangement must at least partially be inserted. Said arrangement enables the instruments, which are used to examine/manipulate cavities, even when the arrangement and/or the instrument is displaced in a translatory and/or rotational manner, in particular, in angled cavities, to be guided in a reliable manner.

Abstract: A lighter for heating-up a smokeless cigarette comprises a housing having a fuel reservoir connected with a burner nozzle via a valve. An igniting device is disposed near the burner nozzle. The valve is openable by an actuator provided on the housing, whereby a flame is ignited by the igniting device. A receptacle is disposed adjacent to the burner nozzle and the igniting device, is accessible through a hole in the housing and is formed in the interior of the housing. The end of a cigarette body facing away from a mouthpiece is inserted into the receptacle so that the corresponding end of a heating pipe, which faces towards the burner nozzle, is heated by the flame in order to vaporize a stimulant in the cigarette. The cigarette can be removed from the receptacle after the stimulant begins to vaporize.

Abstract: A Cigarette body for a smoke-free cigarette, the cigarette body (12) of which has a cylindrical body with an air inlet at one end and an air outlet at the other end, an air channel linking the air inlet with the air outlet and a heating device (26) to warm the air passing through the channel, with the end designed with an air outlet attachable to the end of a cylindrical mouthpiece (10) containing a deposit for a pleasure-giving stimulant (58) and designed with a suction opening (18), so that following the application of negative pressure to the suction opening, the pleasure-giving stimulant is evaporated by the warmed air flowing through the channel and exits together with the air via the suction opening, with this characterized by the fact that the surface of the body (24) facing radially outwards contains thermal material which insulates it from the inside and encloses a structuring heat conductor (26) made from thermally conducting material, which is accessible through the air inlet and for which the end

Abstract: Substituted triols are prepared by reducing appropriately substituted carboxylic esters. The substituted triols can be used as active substances in medicaments.

Abstract: The invention relates to intermediate compounds for preparing novel quinolone derivatives- and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.

Abstract: Substituted triols are prepared by reducing appropriately substituted carboxylic esters. The substituted triols can be used as active substances in medicaments.

Abstract: A process and circuit arrangement for regulating the luminous power of a laser diode in an optoelectronic point-by-point or line recording device for recording information on a recording material. A deviation is determined by comparing a luminous power set value to a measured luminous power real value. A fast regulator generates a regulating current based on the deviation. A slow regulator with storage capabilities generates a working point regulating current that determines the working point on a laser diode characteristic curve and that is added to the regulating current to provide the driving current of the laser diode. The luminous power set value and the slow regulator are used during the switching-on periods of the laser diodes at the beginning of the recording periods and during preliminary periods that precede the recording periods.

Abstract: The invention relates to novel quinolone derivatives and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.

Abstract: The invention relates to novel quinolone derivatives and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, to processes for their preparation and to antibacterial agents and feed additives containing them.

Abstract: Novel bactericidal pyrido[1,2,3-d,e,][1,3,4]benzoxadiazine derivatives of the formula (I) ##STR1## in which R.sup.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl or halogen,R.sup.2 independently of R.sup.1 is hydrogen or methyl,R.sup.3 is hydrogen or C.sub.1 -C.sub.4 -alkyl,R.sup.4 is hydrogen, C.sub.1 -C.sub.4 -alkyl optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)-methyl,X.sup.

Abstract: For the treatment of lipoproteinaemia and arteriosclerosis, the new disubstituted pyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl or heteroaryl,R.sup.2 is cycloalkyl or optionally substituted alkyl,R.sup.3 is hydrogen, cycloalkyl, or optionally substituted alkyl, aryl or heteroaryl,x is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--,A is ##STR2## R.sup.6 is hydrogen or alkyl, and R.sup.7 is hydrogen, alkyl, aralkyl or a cation.

Abstract: The invention relates to novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid which are linked to a .beta.-lactam antibiotic, to their salts, to processes for their preparation and to antibacterial agents containing these derivatives.

Abstract: For the treatment of lipoproteinaemia and arteriosclerosis, the new disubstituted pyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl or heteroaryl,R.sup.2 is cycloalkyl or optionally substituted alkyl,R.sup.3 is hydrogen, cycloalkyl, or optionally substituted alkyl, aryl or heteroaryl,X is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--,A is ##STR2## R.sup.6 is hydrogen or alkyl, and R.sup.7 is hydrogen, alkyl, aralkyl or a cation.

Abstract: The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by a partly hydrogenated isoindolinyl ring, processes for their preparation and antibacterial agents and feed additives containing these compounds.

Abstract: Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines are prepared by reducing corresponding 4-phenyl-pyridone and 4-phenyl-2-alkoxypyridine derivatives. The substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines can be employed as active compounds in medicaments, in particular for the treatment of hyperlipoproteinaemia.

Abstract: New substituted pyridines are prepared by reducing suitably substituted pyridine derivatives. The new substituted pyridines are suitable as active compounds in pharmaceuticals, in particular for the treatment of hyperlipoproteinaemia.

Abstract: Novel compounds for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis of the formula ##STR1## in which A, B, D and E can have varied meanings,X is --CH.sub.2 --CH.sub.2 or --CH.dbd.CH--, andR is ##STR2## wherein R.sup.21 --denotes hydrogen or alkyl andR.sup.22 --denotes hydrogen,denotes alkyl, aryl or aralkyl, ordenotes a cation,and their oxidation products.

Abstract: Intermediate imino-substituted pyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl,R.sup.2 is optionally substituted aryl or alkyl, OH, alkoxy, aralkoxy, or optionally substituted aryloxy,R.sup.3 is isopropyl,R.sup.4 is isopropylX is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--,R is ##STR2## R.sup.6 is H or alkyl, and R.sup.7 is H, alkyl, phenylalkyl, aryl or a cation, and their salts.

Abstract: Substituted pyridyl-dihydroxy-heptenoic acid of the formula ##STR1## and its salts, if desired in an isomeric form, have a superior inhibitory action on HMG-CoA reductase and thus bring about a surprisingly good lowering of the cholesterol content in the blood.